Subhash Banerjee

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Deep Patient: An Unsupervised Representation to Predict the Future of Patients from the Electronic Health Records

Lp-PLA2- a novel risk factor for high-risk coronary and carotid artery disease

Nanoparticles responsive to the inflammatory microenvironment for targeted treatment of arterial restenosis

Fourth Universal Definition of Myocardial Infarction (2018)

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Perioperative Management of Antithrombotic Therapy

Phospholipase A2s: Developing drug targets for atherosclerosis

Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial

Exercise Standards for Testing and Training

Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes

Improved Cardiovascular Risk Prediction Using Nonparametric Regression and Electronic Health Record Data

Atherosclerosis: current pathogenesis and therapeutic options

Risk of Major Adverse Cardiac Events Following Noncardiac Surgery in Patients With Coronary Stents

Radiation exposure in relation to the arterial access site used for diagnostic coronary angiography and percutaneous coronary intervention: a systematic review and meta-analysis

The Cost of Hyperkalemia in the United States

Previous Coronary Stent Implantation and Cardiac Events in Patients Undergoing Noncardiac Surgery

Antithrombotic Therapy for VTE Disease

Characterization of Post-Operative Risk Associated With Prior Drug-Eluting Stent Use

Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE

Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

Comparison by Meta-Analysis of Drug-Eluting Stents and Bare Metal Stents for Saphenous Vein Graft Intervention

Executive Summary

ROS-scavenging hydrogel to promote healing of bacteria infected diabetic wounds

Changes in Plaque Lipid Content After Short-Term Intensive Versus Standard Statin Therapy

Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management

Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis

Non-Fibroatheroma Lesion Phenotype and Long-Term Clinical Outcomes

Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery

Management of patients with cardiac stents undergoing noncardiac surgery

Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic target

The Perioperative Management of Antithrombotic Therapy

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults

Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis

Non-adherence to cardiovascular medications

Clopidogrel and proton pump inhibitors - where do we stand in 2012?

Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of ‘bridging’ antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel

Discontinuation of antiplatelet therapy prior to low‐risk noncardiac surgery in patients with drug‐eluting stents: A retrospective cohort study

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

Real-World Evidence — What Is It and What Can It Tell Us?

Heart failure: epidemiology and prevention in India.

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

Development of Citrate‐Based Dual‐Imaging Enabled Biodegradable Electroactive Polymers

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications

Antiplatelet Therapy and Proton Pump Inhibition

Antiplatelet and Anticoagulation Therapy for Acute Coronary Syndromes

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

Pragmatic clinical trials: Emerging challenges and new roles for statisticians

Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas

2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

Predicting Restenosis of Drug-Eluting Stents Placed in Real-World Clinical Practice

Guidelines for the Primary Prevention of Stroke

Mechanisms of Plaque Formation and Rupture

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Fourth Universal Definition of Myocardial Infarction (2018)

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Reactive Oxygen Species (ROS)-Based Nanomedicine

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Fourth universal definition of myocardial infarction (2018)

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Endothelial cells in physiology and in the pathophysiology of vascular disorders.

Phospholipase A₂Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention

Organ preference of metastasis. The role of organ-specifically modulated endothelial cells.

Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack

Synthesis of RGD-peptide modified poly(ester-urethane) urea electrospun nanofibers as a potential application for vascular tissue engineering

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Global burden of heart failure: a comprehensive and updated review of epidemiology

Lipoprotein-Associated Phospholipase A2 (Lp-PLA₂): A Novel and Promising Biomarker for Cardiovascular Risks Assessment

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Predictors of Hyperkalemia and Death in Patients With Cardiac and Renal Disease

Medical Management After Coronary Stent Implantation

Risk of Noncardiac Surgery After Coronary Drug-Eluting Stent Implantation

Cardiovascular Outcomes in Male Veterans With Rheumatoid Arthritis

Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry

Perioperative Management of Patients With Coronary Stents

Influence of race and sex on lipoprotein-associated phospholipase A2 levels: Observations from the Dallas Heart Study

A Randomized Comparison of the Transradial and Transfemoral Approaches for Coronary Artery Bypass Graft Angiography and Intervention

Outcomes of Patients With Acute Coronary Syndrome and Previous Coronary Artery Bypass Grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] Trials)

Reproducibility of intravascular ultrasound virtual histology analysis

Effect of Concomitant Use of Clopidogrel and Proton Pump Inhibitors After Percutaneous Coronary Intervention

Continued Benefit From Paclitaxel-Eluting Compared With Bare-Metal Stent Implantation in Saphenous Vein Graft Lesions During Long-Term Follow-Up of the SOS (Stenting of Saphenous Vein Grafts) Trial

Outcomes of a preoperative “bridging” strategy with glycoprotein IIb/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration

Multi-Ligand Poly(l-Lactic-co-Glycolic Acid) Nanoparticles Inhibit Activation of Endothelial Cells

A Randomized Controlled Trial of a Paclitaxel-Eluting Stent Versus a Similar Bare-Metal Stent in Saphenous Vein Graft Lesions

Evolution of the American College of Cardiology/American Heart Association Clinical Guidelines

In vivo characterization of coronary plaques: novel findings from comparing greyscale and virtual histology intravascular ultrasound and near-infrared spectroscopy

Frequency and risk of noncardiac surgery after drug‐eluting stent implantation

Association of Lipoprotein-Associated Phospholipase A2 Mass and Activity with Coronary and Aortic Atherosclerosis: Findings from the Dallas Heart Study

Quality of Care for Acute Coronary Syndrome Patients With Known Atherosclerotic Disease

Effect of PCSK9 Inhibitors on Clinical Outcomes in Patients With Hypercholesterolemia: A Meta‐Analysis of 35 Randomized Controlled Trials

In SituRe-endothelializationviaMultifunctional Nanoscaffolds

Outcomes of preoperative bridging therapy for patients undergoing surgery after coronary stent implantation: A weighted meta‐analysis of 280 patients from eight studies